BWM
IMGN

Baystate Wealth Management’s Immunogen Inc IMGN Stock Holding History

Baystate Wealth Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$715K Buy
+24,106
New +$480K 0.05% 119
2020
Q4 		– Sell
-6
Closed – – 781
2020
Q3 		$0 Buy
+6
New +$24 ﹤0.01% 758
2017
Q1 		– Sell
-215
Closed -$1K – 681
2016
Q4 		$1K Buy
+215
New +$432 ﹤0.01% 423

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Baystate Wealth Management's IMGN Position: Q4 2023 in Review

Baystate Wealth Management opened a new position in Immunogen Inc (IMGN) in Q4 2023: 24,106 shares worth $715K. The stake represents 0.05% of the portfolio and ranks #119 among its holdings. This is a return to the name: Baystate Wealth Management previously reported a position in IMGN as recently as Q3 2020.

Baystate Wealth Management first reported a position in IMGN in Q4 2016 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Baystate Wealth Management held 24,106 shares of Immunogen Inc worth $715K as of Q4 2023.
  • Immunogen Inc was a new Baystate Wealth Management position in Q4 2023.
  • Immunogen Inc made up 0.05% of Baystate Wealth Management's portfolio in Q4 2023, its #119 holding.
  • Baystate Wealth Management first reported a position in Immunogen Inc in Q4 2016 and has held it in 3 quarters since.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.